sk&f 81297 and methamphetamine

sk&f 81297 has been researched along with methamphetamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, J; Ichimaru, Y; Mori, T; Suzuki, T1
Fukui, R; Greengard, P; Higashi, H; Matsuishi, T; Nairn, AC; Nishi, A; Svenningsson, P1
Hiranita, T; Nawata, Y; Yamamoto, T1
Ishizuka, M; Ito, S; Kawamoto, K; Otsuguro, K1
Fukushima, T; Furukawa-Hibi, Y; Hashimoto, R; Kondo, M; Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Nitta, A; Ohi, K; Song, Z; Takeda, M; Tanaka, J; Toriumi, K; Yamada, K; Yamamori, H1

Other Studies

5 other study(ies) available for sk&f 81297 and methamphetamine

ArticleYear
Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice.
    Japanese journal of pharmacology, 2000, Volume: 83, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Agents; Locomotion; Male; Methamphetamine; Mice; Morphine; Phencyclidine; Phosphodiesterase Inhibitors; Rolipram

2000
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice.
    Journal of neurochemistry, 2003, Volume: 87, Issue:6

    Topics: Aging; Animals; Animals, Newborn; Benzazepines; Cocaine; Dopamine; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Immunoblotting; In Vitro Techniques; Male; Methamphetamine; Methylphenidate; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Tissue Proteins; Phosphoproteins; Phosphorylation; Signal Transduction; Threonine

2003
A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
    Neuroscience, 2010, Jan-20, Volume: 165, Issue:2

    Topics: Adrenergic Agents; Amisulpride; Amphetamine-Related Disorders; Animals; Benzazepines; Benzofurans; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Methamphetamine; Rats; Rats, Wistar; Self Administration; Sulpiride

2010
Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats.
    British journal of pharmacology, 2012, Volume: 166, Issue:2

    Topics: Animals; Animals, Newborn; Benzazepines; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Ganglia, Spinal; In Vitro Techniques; Male; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Reflex; Spinal Cord; Synaptic Transmission

2012
Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:3

    Topics: Acetyltransferases; Adult; Animals; Benzazepines; Cell Cycle Proteins; Central Nervous System Stimulants; Chlorocebus aethiops; Conditioning, Operant; COS Cells; Dopamine Agonists; Female; Gene Expression Regulation; Humans; Male; Methamphetamine; Mice; Mice, Knockout; Middle Aged; Motor Activity; Neurons; Nucleus Accumbens; Polymorphism, Single Nucleotide; Receptors, Dopamine D1

2014